Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (321-330 of 357) with videos related to

Pageof 36
Sort By:
European Urology|October 29, 2010
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extensionJuan I Martínez-Salamanca, William C Huang, Isabel Millán, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2014
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapyMartin H Voss, A Ari Hakimi, Can G Pham, et al.
Breast Cancer Research : BCR|July 3, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2021
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaJack P Gleeson, Ines Nikolovski, Renzo Dinatale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell CarcinomaKyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
European Urology|January 19, 2021
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT TrialRobert J Motzer, Paul Russo, Naomi Haas, et al.
Pageof 36

Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
European Urology|October 29, 2010
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extensionJuan I Martínez-Salamanca, William C Huang, Isabel Millán, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2014
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapyMartin H Voss, A Ari Hakimi, Can G Pham, et al.
Breast Cancer Research : BCR|July 3, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2021
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaJack P Gleeson, Ines Nikolovski, Renzo Dinatale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell CarcinomaKyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
European Urology|January 19, 2021
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT TrialRobert J Motzer, Paul Russo, Naomi Haas, et al.
Pageof 36